Russia’s Sputnik V COVID-19 Vaccine Starts EU Rolling Review
‘A Major Step’ Towards Approval, Say Backers
Executive Summary
The Russian backers of the vaccine’s development say that if it receives a marketing authorization in the EU, distribution could begin in June this year.
You may also be interested in...
Will Serum Institute Join Strides, Gland On The Sputnik V Flight?
While speculation mounts about Serum Institute being next in line for an RDIF partnership, Gland Pharma and Strides unit Stelis sign up to make COVID-19 vaccine Sputnik V. Part of the 550 million dose output tied up from India so far could be consumed domestically, but exports are a possibility as demand from European countries is set to jump.
Russians Attack 'Negative' EMA Comments On National Sputnik V Authorizations
Politics are never far from the surface where coronavirus vaccines are concerned, as demonstrated by recent comments by the Sputnik V developers.
Slovakia Becomes Second EU Country To OK Use Of Russian Vaccine
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.